SCHEMBL25708352

SCHEMBL25708352

Cn1c2cc3ccccc3cc2n2c3cc4ccccc4cc3nc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.56
LMNA P02545 3/20 0.56
ALDH1A1 P00352 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.45
HSD17B10 Q99714 2/20 0.45
NPC1 O15118 1/20 0.45
TP53 P04637 1/20 0.45
GLA P06280 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
NFKB1 P19838 1/20 0.45
RAB9A P51151 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
IKBKB O14920 5/20 0.42
CHUK O15111 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25708282 0.91 KDM4E (0.54) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL25708331 0.88 ATM (0.47) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL13852950 0.81 ALDH1A1 (0.52) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL25708365 0.80 KDM4E (0.46) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL25708334 0.80 KDM4E (0.46) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL25708351 0.78 PDE10A (0.42) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL18805384 0.77 ALDH1A1 (0.48) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL25708353 0.76 TLR8 (0.41) KDM4ELMNAALDH1A1HSD17B10NPC1
SCHEMBL22063137 0.75 KDM4E (0.43) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10
SCHEMBL25693507 0.75 ATM (0.45) KDM4ELMNAALDH1A1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230209993-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230209993-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, LAGE3, NQO1 KDM4E 2980/4885LMNA 1267/4885ALDH1A1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.